SHANGHAI, Feb. 02, 2026 — Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic firm based in Shanghai, has announced an agreement to purchase the innovative ophthalmic device operations of Hangzhou-based MDCO Technology.
This planned acquisition will incorporate MDCO’s high-end intraocular lens (IOL), implantable contact lens (Phakic Lens), and refractive device platforms into Arctic Vision’s worldwide innovation structure. It will bolster Arctic Vision’s global ophthalmic business by merging sophisticated device engineering and smart manufacturing with its current innovative strengths.
Advancing Global Ophthalmic Innovation in Both Drug and Device
The planned deal is consistent with Arctic Vision’s long-term strategy, broadening its portfolio with novel therapeutics that address significant unmet medical needs.
The merger is anticipated to forge a leading industry pipeline, combining Arctic Vision’s extensive research and development expertise in retinal, ocular surface, and neuro-ophthalmic fields with MDCO’s design and manufacturing know-how in IOL and Phakic Lens technologies.
As per the agreement, MDCO will become a fully owned subsidiary of Arctic Vision. The combined entity will continue essential operations in Shanghai (for biopharmaceutical R&D, regulatory affairs, and operations), Hangzhou (for implanted device R&D, manufacturing, and commercial management), and California (for design and global collaboration).
Leadership Perspectives
“This deal marks a crucial move in Arctic Vision’s long-term expansion plan,” stated Dr. Eddy Wu, Founder, Chairman and CEO of Arctic Vision. “By combining MDCO’s ophthalmic device platforms with Arctic Vision’s pharmaceutical innovation strengths, we are creating a fully integrated ophthalmic innovation ecosystem that merges scientific prowess with advanced manufacturing and commercial reach. We are constructing a company with a structure ready for wider global investment and future capital market prospects, while enhancing our capacity to serve more patients and make a greater worldwide impact in ophthalmology.”
“Joining Arctic Vision’s integrated platform begins a new era for MDCO,” said Mr. Liang Liu, Chairman of MDCO Technology. “MDCO’s signature intraocular and refractive products will gain from Arctic Vision’s robust R&D and regulatory infrastructure, allowing for faster development and expanded global market entry.”
About Arctic Vision
Arctic Vision is a worldwide ophthalmic innovation company with its headquarters in Shanghai, China, focused on creating and commercializing next-generation treatments for retinal disease, dry eye, and ocular neuroprotection. Operating globally with a presence in Hong Kong and the U.S., Arctic Vision uses its internal platform and strategic alliances to propel innovation from early-stage discovery to commercialization.
About MDCO Technology
MDCO Technology Co., Ltd. is an innovator in ophthalmic medical devices, specializing in intraocular and refractive lens systems. It maintains R&D and production facilities in Hangzhou, China, and California, U.S. The Hangzhou location acts as the hub for device R&D, manufacturing, operations, and commercial management in China. With almost twenty years of expertise in materials science and precision molding, MDCO is dedicated to premium solutions for cataract and myopia correction and is known for its intelligent manufacturing and surgical-platform innovations.
Forward-Looking Statements
This press release includes forward-looking statements concerning the completion and anticipated advantages of the proposed merger, future growth plans, regulatory clearances, product development timelines, revenue prospects, pipeline advancement, market potential, and possible access to capital markets. These statements involve risks and uncertainties, such as the ability to meet closing conditions, shifts in regulatory or market environments, the success of integrating operations and achieving expected synergies, and other factors detailed in public filings by Arctic Vision and MDCO Technology. Actual outcomes could vary significantly, and neither company commits to updating these statements unless legally required.
Media Contacts
Arctic Vision – Corporate Communications
communications@arcticvision.com
MDCO Technology – Investor Relations
ir@mdcotech.com
